A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia
- 15 August 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 98 (4), 1166-1173
- https://doi.org/10.1182/blood.v98.4.1166
Abstract
The hematopoietic stem cell underlying acute myeloid leukemia (AML) is controversial. Flow cytometry and the DNA-binding dye Hoechst 33342 were previously used to identify a distinct subset of murine hematopoietic stem cells, termed the side population (SP), which rapidly expels Hoechst dye and can reconstitute the bone marrow of lethally irradiated mice. Here, the prevalence and pathogenic role of SP cells in human AML were investigated. Such cells were found in the bone marrow of more than 80% of 61 patients and had a predominant CD34low/− immunophenotype. Importantly, they carried cytogenetic markers of AML in all 11 cases of active disease examined and in 2 out of 5 cases in complete hematological remission. Comparison of daunorubicin and mitoxantrone fluorescence emission profiles revealed significantly higher drug efflux from leukemic SP cells than from non-SP cells. Three of 28 SP cell transplants generated overt AML-like disease in nonobese diabetic–severe combined immunodeficient mice. Low but persistent numbers of leukemic SP cells were detected by molecular and immunological assays in half of the remaining mice. Taken together, these findings indicate that SP cells are frequently involved in human AML and may be a target for leukemic transformation. They also suggest a mechanism by which SP cells could escape the effects of cytostatic drugs and might eventually contribute to leukemia relapse.Keywords
This publication has 19 references indexed in Scilit:
- Engraftment and Multilineage Expression of Human Bone Marrow CD34− Cells In VivoaAnnals of the New York Academy of Sciences, 1999
- Most Acute Myeloid Leukemia Progenitor Cells With Long-Term Proliferative Ability In Vitro and In Vivo Have the Phenotype CD34+/CD71−/HLA-DR−Blood, 1998
- In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fraction.Leukemia, 1998
- A newly discovered class of human hematopoietic cells with SCID-repopulating activityNature Medicine, 1998
- Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple speciesNature Medicine, 1997
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.The Journal of Experimental Medicine, 1996
- A cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature, 1994
- Clonal Chromosomal Abnormalities Showing Multiple-Cell-Lineage Involvement in Acute Myeloid LeukemiaNew England Journal of Medicine, 1988
- Acute nonlymphocytic leukemia: heterogeneity of stem cell originBlood, 1981